Howe & Rusling Inc Macrogenics Inc Call Options Transaction History
Howe & Rusling Inc
- $1.16 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding MGNX
# of Institutions
133Shares Held
53MCall Options Held
45.1KPut Options Held
143K-
Bellevue Group Ag Kuesnacht, V89.93MShares$15.5 Million0.29% of portfolio
-
Armistice Capital, LLC New York, NY6.3MShares$9.82 Million0.12% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$8.43 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$6.9 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$5.07 Million0.02% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $95.9M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...